2022
DOI: 10.1016/j.aca.2021.339316
|View full text |Cite
|
Sign up to set email alerts
|

Discovery and quantification of lipoamino acids in bacteria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

4
1

Authors

Journals

citations
Cited by 6 publications
(13 citation statements)
references
References 36 publications
(41 reference statements)
1
11
0
Order By: Relevance
“…As the abundance of L. murinus IRSD_2020 was inversely correlated to the visceral sensitivity, we hypothesised that these bacteria produced a metabolite decreasing visceral sensitivity. Based on our previous study where we described the production of an analgesic GABA-containing lipopeptide by E. coli strain14 14 and on our studies identifying several lipoamines in bacteria,15 16 we developed a method to quantify the concentration of lipopeptides containing GABA: C12AlaGABA, C12AsnGABA, C14AsnGABA, C14:1AlaGABA, C12ValGABA, C12LeuGABA, C14GABA, C12IleGABA, C14IleGABA, C16LeuGABA, C16PheGABA and C16GluGABA (online supplemental methods). In L. murinus IRSD_2020, as no clear production of lipopeptides-GABA was observed (online supplemental figure 6A and table S5) and as these bacteria did not express the enzymes implicated in GABA synthesis, we cultured L. murinus IRSD_2020 in the presence of GABA.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…As the abundance of L. murinus IRSD_2020 was inversely correlated to the visceral sensitivity, we hypothesised that these bacteria produced a metabolite decreasing visceral sensitivity. Based on our previous study where we described the production of an analgesic GABA-containing lipopeptide by E. coli strain14 14 and on our studies identifying several lipoamines in bacteria,15 16 we developed a method to quantify the concentration of lipopeptides containing GABA: C12AlaGABA, C12AsnGABA, C14AsnGABA, C14:1AlaGABA, C12ValGABA, C12LeuGABA, C14GABA, C12IleGABA, C14IleGABA, C16LeuGABA, C16PheGABA and C16GluGABA (online supplemental methods). In L. murinus IRSD_2020, as no clear production of lipopeptides-GABA was observed (online supplemental figure 6A and table S5) and as these bacteria did not express the enzymes implicated in GABA synthesis, we cultured L. murinus IRSD_2020 in the presence of GABA.…”
Section: Resultsmentioning
confidence: 99%
“…In a previous study, we highlighted that a probiotic, Escherichia coli Nissle 1917, produces a lipopeptide, the C12-asparagine-γ-aminobutyric acid (C12AsnGABA) that decreases both neuronal activation induced by pro-nociceptive molecules in vitro and capsaicin-induced hypersensitivity in vivo 14. We then determined lipoamino acid (LpAA) and GABA–lipopeptide structures by high-resolution mass spectrometry and developed a quantitative method of newly identified LpAA and lipopeptide–GABA by liquid chromatography coupled to mass spectrometry (LC-MS/MS) in different strains of bacteria 15 16…”
Section: Introductionmentioning
confidence: 99%
“…Recently, CID from nonresonant activation of [C16Glu-H] − ( m / z 384) using Qq/TOF MS was shown to unexpectedly yield the fatty acid [(C16Glu-H)-(Glu-H 2 O)] − ( m / z 255) carboxylate regeneration and its complementary [(Glu-H)-H 2 O] − dehydrated glutamate ( m / z 128). Regeneration of the fatty acid carboxylate was unexpected since, under same collisional conditions, it did not occur from [ Lp AA-H] − consisting of a basic or nonpolar chain . The exclusive formation of such a long chain carboxylate from [ Lp Glu-H] − ( Lp as the C12 and C16 acyl conjugates) particularly attracted our attention in this study, since its breakdown profile, constituting the ERMS of [ Lp Glu-H] − appears as a broadened monomodal curve (compared to the other product ion profiles).…”
Section: Introductionmentioning
confidence: 91%
“…Overall the SPPS strategy allowed to access in minimum time and high purity to a large set of new lipopeptides necessary for the discovery and quantification of lipoamino acids in bacteria [76] …”
Section: Lipopeptidesmentioning
confidence: 99%
“…[73] necessary for the discovery and quantification of lipoamino acids in bacteria. [76] 7. Cysteinyl-SPM Specialized proresolving mediators (SPM) are oxylipins that are actively involved in the clearance and regulation of inflammatory exudates to allow the restoration of tissue homeostasis.…”
Section: Lipopeptidesmentioning
confidence: 99%